What Does Nimbus Therapeutics Do?

Total employees110
HeadquartersCambridge
Founded2009

Nimbus Therapeutics is a biotechnology company at the forefront of computational drug discovery. They leverage advanced computational technologies, including physics-based molecular simulations and machine learning, to design and develop breakthrough medicines for a range of serious diseases, focusing on targets that have historically been challenging for traditional drug discovery methods. Their pipeline spans oncology, immunology, and metabolic disorders, with a key focus on harnessing computational power to accelerate the creation of transformative therapies.

Where Is Nimbus Therapeutics's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for Nimbus's research and development, computational drug design, corporate strategy, and administrative operations.

Notable Features:

Situated in the heart of Cambridge's biotech cluster, offering modern lab and office spaces designed for collaborative, cutting-edge computational and biological research.

Work Culture:

A dynamic, science-first environment emphasizing innovation, collaboration across disciplines (computational sciences, chemistry, biology), and a mission-driven approach to tackling challenging drug targets. The culture encourages rigorous scientific debate and a fast-paced, results-oriented mindset.

HQ Significance:

Strategic location in Cambridge grants Nimbus direct access to world-class talent from institutions like MIT and Harvard, leading research hospitals, a dense network of biotech peers, and venture capital, fostering innovation and strategic partnerships.

Values Reflected in HQ: The headquarters' design and location reflect Nimbus's core values of scientific excellence, innovation, and collaboration, providing an environment conducive to cutting-edge research and interdisciplinary teamwork.

Location:

While Nimbus Therapeutics's core research and development operations are based in Cambridge, MA, its scientific collaborations, clinical trial activities, and talent acquisition efforts extend globally. The company engages with international research institutions, contract research organizations (CROs), and clinical sites to advance its pipeline. Its medicines are being developed for diseases that affect patients worldwide, giving its mission a global scope.

Street Address:

130 Brookline Street, Suite 200

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Nimbus Therapeutics Operate Around the World?

N/A

Address: N/A

Focus on centralized research & development and corporate functions within the Cambridge biotech ecosystem.

Buying Intent Signals for Nimbus Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Nimbus Therapeutics? Meet the Executive Team

As of April 2025, Nimbus Therapeutics' leadership includes:

Jeb Keiper, M.S., M.B.A. - Chief Executive Officer
Peter G. Traber, M.D. - Chief Medical Officer
Anne C. G. Hotz-Behofsits, J.D., Ph.D. - Chief Operating Officer
Abbas Kazimi - Chief Business Officer
Bhaskar Srivastava, Ph.D. - Chief Technology Officer
Christine W. Horton, M.B.A. - Chief People and Culture Officer

Who's Investing in Nimbus Therapeutics?

Nimbus Therapeutics has been backed by several prominent investors over the years, including:

Access Biotechnology
Atlas Venture
BVF Partners L.P.
Bain Capital Life Sciences
Bill Gates
GV (Google Ventures)
Lightstone Ventures
Omega Funds
Pfizer Ventures
RA Capital Management
Schrödinger, Inc.
SR One

What Leadership Changes Has Nimbus Therapeutics Seen Recently?

Hire2
Exits0

Nimbus Therapeutics significantly strengthened its executive team in the past year with strategic hires for Chief Business Officer and Chief Technology Officer, reflecting its commitment to advancing its pipeline and computational platform. No major C-level departures were publicly announced during this period.

New Appointments:

Abbas Kazimi, Abbas Kazimi appointed as Chief Business Officer to lead business development and corporate strategy.
Bhaskar Srivastava, Ph.D., Bhaskar Srivastava, Ph.D., appointed as Chief Technology Officer to advance Nimbus's computational drug discovery engine.

What Technology (Tech Stack) Is Used byNimbus Therapeutics?

Discover the tools Nimbus Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Nimbus Therapeutics Email Formats and Examples

Nimbus Therapeutics commonly uses the [first].[last]@nimbustx.com email format. Other potential formats might exist but this is a frequently observed pattern for companies of similar structure and industry.

[first].[last]@nimbustx.com

Format

jeb.keiper@nimbustx.com

Example

80%

Success rate

What's the Latest News About Nimbus Therapeutics?

Business WireFebruary 27, 2024

Nimbus Therapeutics Announces $125 Million Private Financing to Advance Broad Portfolio of Product Candidates for Autoimmune Diseases, Cancer and Metabolic Disorders

Nimbus Therapeutics secured $125 million in a private financing round. The funds are designated to advance its diverse pipeline, including its lead HPK1 inhibitor (NDI-101150) for immuno-oncology, and other programs targeting autoimmune diseases, cancer, and metabolic conditions....more

Nimbus Therapeutics Press ReleaseFebruary 14, 2024

Nimbus Therapeutics Appoints Abbas Kazimi as Chief Business Officer

Nimbus Therapeutics announced the appointment of Abbas Kazimi as its new Chief Business Officer. Mr. Kazimi will lead the company's business development, corporate strategy, and alliance management functions....more

Nimbus Therapeutics Press ReleaseSeptember 12, 2023

Nimbus Therapeutics Appoints Bhaskar Srivastava, Ph.D., as Chief Technology Officer

Nimbus Therapeutics appointed Bhaskar Srivastava, Ph.D., as its Chief Technology Officer. Dr. Srivastava will oversee the company's computational platform, data science, and information technology efforts to further enhance its drug discovery capabilities....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Nimbus Therapeutics, are just a search away.